BRIEF-Loxo Oncology acquires BTK inhibitor program

* Loxo Oncology announces acquisition of highly selective,reversible BTK inhibitor program
The post BRIEF-Loxo Oncology acquires BTK inhibitor program appeared first on RocketNews | Top News Stories From Around the Globe.